Lactated Ringer's and PlasmaLyte in Critically Ill Adults

NCT ID: NCT03813563

Last Updated: 2019-01-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

12000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-13

Study Completion Date

2019-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In recent years, there has been a large amount of literature reports that normal saline can increase the incidence of renal injury in critically ill patients compared with balanced salt solution.However, no studies have compared the effects of different types of balanced salt solutions on the incidence of renal injury.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mix group

Patients who used two balanced salt solutions during icu stay

RL

Intervention Type DRUG

lactated Ringer's

PLA

Intervention Type DRUG

PlasmaLyte

RL group

Patients who have only used lactated Ringer's during icu stay

RL

Intervention Type DRUG

lactated Ringer's

PLA group

Patients who have only used PlasmaLyte during icu stay

PLA

Intervention Type DRUG

PlasmaLyte

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RL

lactated Ringer's

Intervention Type DRUG

PLA

PlasmaLyte

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients admitted to ICU

Exclusion Criteria

* Patients \<18 year old when admission
* Patients who stay less than 24 hours in ICU
* Patients who do not sufficient data for further analysis
* Readmission patients during the study period
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

West China Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kang Yan

Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Critical care medicine of West China Hospital

Chengdu, Sichuan, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RL vs Plalyte

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

I USE LR in the ED
NCT03807648 COMPLETED
Plasma-Lyte 148® versUs Saline Study
NCT02721654 COMPLETED PHASE4
Fluids in Sepsis and Septic Shock
NCT02748382 COMPLETED PHASE2/PHASE3